Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kenneth Lundstrom. (2018) New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy. Biologics: Targets and Therapy 12, pages 43-60.
Read now
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Read now
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 6:12.
Read now
Read now
Articles from other publishers (55)
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang & Mingjuan Du. (2023) Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy - Oncolytics 30, pages 275-285.
Crossref
Crossref
Claire Battin, Annika De Sousa Linhares, Judith Leitner, Anna Grossmann, Daniela Lupinek, Shiva Izadi, Alexandra Castilho, Petra Waidhofer-Söllner, Katharina Grabmeier-Pfistershammer, Jochen Stritzker & Peter Steinberger. (2023) Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents. Cancer Immunology, Immunotherapy 72:9, pages 3029-3043.
Crossref
Crossref
Noelia Silva-Pilipich, Ángela Covo-Vergara & Cristian Smerdou. (2023) Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors. Cancers 15:8, pages 2352.
Crossref
Crossref
Alessia Floerchinger, Jessica E. Klein, Maximiliane S. C. Finkbeiner, Theresa E. Schäfer, Gwendolin Fuchs, Johannes Doerner, Hubert Zirngibl, Maximilian Ackermann, Hans M. Kvasnicka, Kerry A. Chester, Dirk Jäger, Claudia R. Ball, Guy Ungerechts & Christine E. Engeland. (2023) A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. Cell Death & Disease 14:2.
Crossref
Crossref
Rūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, Chin Leng Tan, Theresa E. Schäfer, Na Kang, Claudia R. Ball, Jonas Leichsenring, Albrecht Stenzinger, Lars Kaderali, Dirk Jäger, Guy Ungerechts & Christine E. Engeland. (2023) Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model. Frontiers in Immunology 13.
Crossref
Crossref
Noelia Silva-Pilipich, Ángela Covo-Vergara, Lucía Vanrell & Cristian Smerdou. 2023. Viral Vectors in Cancer Immunotherapy. Viral Vectors in Cancer Immunotherapy
43
86
.
Dustin Eckhardt, Sascha Bossow, Jan-Philip Klee, Björn Boshof, Guy Ungerechts, Peter Czermak & Denise Salzig. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs)
375
405
.
Maya A. Dymova, Anna S. Kichkailo, Elena V. Kuligina & Vladimir A. Richter. (2022) Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy. Pharmaceutics 15:1, pages 151.
Crossref
Crossref
Han Hu, Siqi Zhang, Linkang Cai, Haixiao Duan, Yuying Li, Junhan Yang, Yang Wang, Biao Liu, Shuang Dong, Zhizheng Fang & Binlei Liu. (2022) A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy. Virology Journal 19:1.
Crossref
Crossref
Karina Spunde, Ksenija Korotkaja & Anna Zajakina. (2022) Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations. Biomedicines 10:9, pages 2142.
Crossref
Crossref
Qing Ji, Yuchen Wu, Andreas Albers, Meiyu Fang & Xu Qian. (2022) Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches. Pharmaceutics 14:9, pages 1811.
Crossref
Crossref
Yaomei Tian, Daoyuan Xie & Li Yang. (2022) Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Rūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, Lara M. Jeworowski, Linda Küther, Christian J. Buchholz, Dirk Jäger, Guy Ungerechts & Christine E. Engeland. (2022) Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory. Molecular Therapy - Oncolytics 24, pages 43-58.
Crossref
Crossref
Jian WangTao LiuJie Chen. (2021)
Oncolytic Measles Virus Encoding Interleukin-12 Mediated Antitumor Activity and Immunologic Control of Colon Cancer
In Vivo
and
Ex Vivo
. Cancer Biotherapy and Radiopharmaceuticals 36:9, pages 774-782.
Crossref
Crossref
Andrea Vannini, Federico Parenti, Daniela Bressanin, Catia Barboni, Anna Zaghini, Gabriella Campadelli-Fiume & Tatiana Gianni. (2021) Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSV. Viruses 13:10, pages 2085.
Crossref
Crossref
Cole W. D. Peters & Fares Nigim. (2021) Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules. International Journal of Molecular Sciences 22:16, pages 9051.
Crossref
Crossref
Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E. Engeland, Henry Fechner, Karsten Geletneky, Katrin Goepfert, Per Sonne Holm, Stefan Kochanek, Florian Kreppel, Lea Krutzke, Florian Kühnel, Karl Sebastian Lang, Antonio Marchini, Markus Moehler, Michael D. Mühlebach, Ulrike Naumann, Roman Nawroth, Jürg Nüesch, Jean Rommelaere, Ulrich M. Lauer & Guy Ungerechts. (2021) Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. Viruses 13:8, pages 1420.
Crossref
Crossref
Hans Martin Singh, Mathias Felix Leber, Sascha Bossow, Christine E. Engeland, Jan Dessila, Christian Grossardt, Karim Zaoui, John C. Bell, Dirk Jäger, Christof von Kalle & Guy Ungerechts. (2021) MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer. Molecular Therapy - Oncolytics 21, pages 340-355.
Crossref
Crossref
D. G. Roy, K. Geoffroy, M. Marguerie, S. T. Khan, N. T. Martin, J. Kmiecik, D. Bobbala, A. S. Aitken, C. T. de Souza, K. B. Stephenson, B. D. Lichty, R. C. Auer, D. F. Stojdl, J. C. Bell & M.-C. Bourgeois-Daigneault. (2021) Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. Nature Communications 12:1.
Crossref
Crossref
Kyoung-Ju Kim, Dahye Moon, So Jung Kong, Yu Seong Lee, Youngeun Yoo, Soyoung Kim, Chan Kim, Hong Jae Chon, Joo-Hang Kim & Kyung-Ju Choi. (2020) Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1. Gene Therapy 28:3-4, pages 186-198.
Crossref
Crossref
Christine E. Engeland & Guy Ungerechts. (2021) Measles Virus as an Oncolytic Immunotherapy. Cancers 13:3, pages 544.
Crossref
Crossref
Christine E. Engeland. (2021)
Re: “Oncolytic Measles Virus Encoding Interleukin-12 Mediated Antitumor Activity and Immunologic Control of Colon Cancer
In Vivo
and
Ex Vivo
” by Wang et al.
. Cancer Biotherapy and Radiopharmaceuticals 36:1, pages 106-107.
Crossref
Crossref
Ianko D. Iankov, Cheyne Kurokawa, Kimberly Viker, Steven I. Robinson, Arun Ammayappan, Eleni Panagioti, Mark J. Federspiel & Evanthia Galanis. (2020) Live Attenuated Measles Virus Vaccine Expressing Helicobacter pylori Heat Shock Protein A. Molecular Therapy - Oncolytics 19, pages 136-148.
Crossref
Crossref
Jonathan G. Pol, Samuel T. Workenhe, Prathyusha Konda, Shashi Gujar & Guido Kroemer. (2020) Cytokines in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 4-27.
Crossref
Crossref
Gemma Pidelaserra-Martí & Christine E. Engeland. (2020) Mechanisms of measles virus oncolytic immunotherapy. Cytokine & Growth Factor Reviews 56, pages 28-38.
Crossref
Crossref
Mathias F. Leber, Serge Neault, Elise Jirovec, Russell Barkley, Aida Said, John C. Bell & Guy Ungerechts. (2020) Engineering and combining oncolytic measles virus for cancer therapy. Cytokine & Growth Factor Reviews 56, pages 39-48.
Crossref
Crossref
Taylor R. Jamieson, Joanna Poutou & Carolina S. Ilkow. (2020) Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment. Cytokine & Growth Factor Reviews 56, pages 102-114.
Crossref
Crossref
Rebecca Burchett, Scott Walsh, Yonghong Wan & Jonathan L. Bramson. (2020) A rational relationship: Oncolytic virus vaccines as functional partners for adoptive T cell therapy. Cytokine & Growth Factor Reviews 56, pages 149-159.
Crossref
Crossref
M. Marotel, M.S. Hasim, A. Hagerman & M. Ardolino. (2020) The two-faces of NK cells in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 59-68.
Crossref
Crossref
Khue G. Nguyen, Maura R. Vrabel, Siena M. Mantooth, Jared J. Hopkins, Ethan S. Wagner, Taylor A. Gabaldon & David A. Zaharoff. (2020) Localized Interleukin-12 for Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Crossref
Lingling Wang, Hui Hui, Kriti Agrawal, Yuqi Kang, Na Li, Rachel Tang, Jiajun Yuan & Tariq M Rana. (2020)
m
6
A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy
. The EMBO Journal 39:20.
Crossref
Crossref
Cunqing Kong, Miao Chen, Xiaohui Fan & Xingcai Chen. (2020) Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis. Journal of International Medical Research 48:8, pages 030006052094342.
Crossref
Crossref
Mathias Felix Leber, Birgit Hoyler, Stefanie Prien, Serge Neault, Christine E. Engeland, Judith M. Förster, Sascha Bossow, Christoph Springfeld, Christof von Kalle, Dirk Jäger, John C. Bell & Guy Ungerechts. (2020) Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations. Journal of General Virology 101:4, pages 399-409.
Crossref
Crossref
Michael D Mühlebach. (2020) Measles virus in cancer therapy. Current Opinion in Virology 41, pages 85-97.
Crossref
Crossref
Elena Busch, Kristina D. Kubon, Johanna K. M. Mayer, Gemma Pidelaserra-Martí, Jessica Albert, Birgit Hoyler, Johannes P. W. Heidbuechel, Kyle B. Stephenson, Brian D. Lichty, Wolfram Osen, Stefan B. Eichmüller, Dirk Jäger, Guy Ungerechts & Christine E. Engeland. (2020) Measles Vaccines Designed for Enhanced CD8+ T Cell Activation. Viruses 12:2, pages 242.
Crossref
Crossref
Hong-My Nguyen, Kirsten Guz-Montgomery & Dipongkor Saha. (2020) Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy. Cells 9:2, pages 400.
Crossref
Crossref
Laura Dietz & Christine E. Engeland. 2020. Oncolytic Viruses. Oncolytic Viruses
111
126
.
Rūta Veinalde. 2020. Oncolytic Viruses. Oncolytic Viruses
213
227
.
Backhaus, Veinalde, Hartmann, Dunder, Jeworowski, Albert, Hoyler, Poth, Jäger, Ungerechts & Engeland. (2019) Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists. Viruses 11:10, pages 914.
Crossref
Crossref
Duo Zhou, Meng-Ying Zhu, Yi-Long Wang, Xiao-Qiang Hao, Dong-Ming Zhou, Rong-Xian Liu, Chu-Di Zhang, Chu-Fan Qu & Zheng-Yan Zhao. (2019) Attenuated MuV-S79 as vector stably expressing foreign gene. World Journal of Pediatrics 15:5, pages 511-515.
Crossref
Crossref
Christine E. Engeland & Guy Ungerechts. (2019) Immuntherapie mit onkolytischen Viren: Wenn Viren Turmorzellen zum „Platzen“ bringen. Deutsches Ärzteblatt Online.
Crossref
Crossref
Francesco Alessandrini, Laura Menotti, Elisa Avitabile, Irene Appolloni, Davide Ceresa, Daniela Marubbi, Gabriella Campadelli-Fiume & Paolo Malatesta. (2019) Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model. Oncogene 38:23, pages 4467-4479.
Crossref
Crossref
Geetanjali Lal & Maitreyi S. Rajala. (2019) Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death. Frontiers in Oncology 8.
Crossref
Crossref
Alfonso R. Sánchez-Paulete, Álvaro Teijeira, José I. Quetglas, María E. Rodríguez-Ruiz, Álvaro Sánchez-Arráez, Sara Labiano, Iñaki Etxeberria, Arantza Azpilikueta, Elixabet Bolaños, María Cristina Ballesteros-Briones, Noelia Casares, Sergio A. Quezada, Pedro Berraondo, David Sancho, Cristian Smerdou & Ignacio Melero. (2018) Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming. Cancer Research 78:23, pages 6643-6654.
Crossref
Crossref
Peter A Forsyth & Daniel Abate-Daga. (2018) Viral Therapy Gets Personal: A Potential Gene Signature to Predict Susceptibility to Measles Virus Oncolysis. JNCI: Journal of the National Cancer Institute 110:10, pages 1139-1140.
Crossref
Crossref
Stacy J. Kowalsky, Zuqiang Liu, Mathilde Feist, Sara E. Berkey, Congrong Ma, Roshni Ravindranathan, Enyong Dai, Edward J. Roy, Zong Sheng Guo & David L. Bartlett. (2018) Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade. Molecular Therapy 26:10, pages 2476-2486.
Crossref
Crossref
Pascale Garnier, Rosemary Mummery, Mark J. Forster, Barbara Mulloy, Roslyn V. Gibbs & Christopher C. Rider. (2018) The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit. Cytokine 110, pages 159-168.
Crossref
Crossref
Valerio Leoni, Andrea Vannini, Valentina Gatta, Julie Rambaldi, Mara Sanapo, Catia Barboni, Anna Zaghini, Patrizia Nanni, Pier-Luigi Lollini, Costanza Casiraghi & Gabriella Campadelli-Fiume. (2018) A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors. PLOS Pathogens 14:8, pages e1007209.
Crossref
Crossref
Laura Menotti, Elisa Avitabile, Valentina Gatta, Paolo Malatesta, Biljana Petrovic & Gabriella Campadelli-Fiume. (2018) HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses. Viruses 10:7, pages 352.
Crossref
Crossref
Tobias Speck, Johannes P.W. Heidbuechel, Rūta Veinalde, Dirk Jaeger, Christof von Kalle, Claudia R. Ball, Guy Ungerechts & Christine E. Engeland. (2018) Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors. Clinical Cancer Research 24:9, pages 2128-2137.
Crossref
Crossref
Mohammed Selman, Christopher Rousso, Anabel Bergeron, Hwan Hee Son, Ramya Krishnan, Nader A. El-Sayes, Oliver Varette, Andrew Chen, Fabrice Le Boeuf, Fanny Tzelepis, John C. Bell, Debbie C. Crans & Jean-Simon Diallo. (2018) Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds. Molecular Therapy 26:1, pages 56-69.
Crossref
Crossref
Matthew J. Atherton, Laura Evgin, Brian A. Keller, Mira M. Shenouda, Kyle B. Stephenson, Richard G. Vile, John C. Bell, David H. Evans & Brian D. Lichty. (2017) Infectious Optimism following the 10th International Oncolytic Virus Meeting. Molecular Therapy - Oncolytics 7, pages 12-16.
Crossref
Crossref
Margaret R. DuffyKerry D. FisherLen W. Seymour. (2017) Making Oncolytic Virotherapy a Clinical Reality: The European Contribution. Human Gene Therapy 28:11, pages 1033-1046.
Crossref
Crossref
Guy UngerechtsChristine E. EngelandChristian J. BuchholzJürgen EberleHenry FechnerKarsten GeletnekyPer Sonne HolmFlorian KreppelFlorian KühnelKarl Sebastian LangMathias F. LeberAntonio MarchiniMarkus MoehlerMichael D. MühlebachJean RommelaereChristoph SpringfeldUlrich M. LauerDirk M. Nettelbeck. (2017) Virotherapy Research in Germany: From Engineering to Translation. Human Gene Therapy 28:10, pages 800-819.
Crossref
Crossref
Daniel Santiago, Johannes Heidbuechel, Wendy Kandell, Rachel Walker, Julie Djeu, Christine Engeland, Daniel Abate-Daga & Heiko Enderling. (2017) Fighting Cancer with Mathematics and Viruses. Viruses 9:9, pages 239.
Crossref
Crossref